Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tecogen (TGEN) Research & Development (2016 - 2025)

Tecogen (TGEN) has disclosed Research & Development for 13 consecutive years, with $297926.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 27.42% year-over-year to $297926.0, compared with a TTM value of $1.1 million through Sep 2025, up 14.42%, and an annual FY2024 reading of $961837.0, up 14.5% over the prior year.
  • Research & Development was $297926.0 for Q3 2025 at Tecogen, up from $268724.0 in the prior quarter.
  • Across five years, Research & Development topped out at $297926.0 in Q3 2025 and bottomed at $122031.0 in Q3 2021.
  • Average Research & Development over 5 years is $207164.1, with a median of $214320.0 recorded in 2023.
  • The sharpest move saw Research & Development crashed 65.38% in 2021, then skyrocketed 65.64% in 2022.
  • Year by year, Research & Development stood at $161015.0 in 2021, then rose by 21.57% to $195747.0 in 2022, then rose by 9.49% to $214320.0 in 2023, then rose by 5.84% to $226843.0 in 2024, then soared by 31.34% to $297926.0 in 2025.
  • Business Quant data shows Research & Development for TGEN at $297926.0 in Q3 2025, $268724.0 in Q2 2025, and $292668.0 in Q1 2025.